مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

533
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

114
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

THE ESTIMATION OF DIRECT MEDICAL COSTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS B AND C IN IRAN

Pages

  191-196

Abstract

 Background: The objective of this study is to estimate the average diagnosis and treatment costs of chronic HEPATITIS B and C, with respect to different therapeutic strategies in Iran.Methods: This is a descriptive, analytical, and cross-sectional study carried out on patients with HEPATITIS B and C, who were referred to the Liver Disease Research Center for Prevention and Treatment of Hepatitis, Isfahan University of Medical Sciences, in 2011. We have estimated the DIRECT MEDICAL COSTS including doctors’ fees, cost of para-clinical tests, medical treatments, and liver biopsy, in different treatment strategies.Findings: The results of this study showed that the total cost of diagnostic services for HEPATITIS B virus (HBV) and HEPATITIS C virus (HCV) patients, with state medical tariffs, was US$ 1499.07 and US$ 2084.89, respectively. The patients’ profiles showed that there were currently seven therapeutic strategies available to treat HBV patients. The total cost of treatment strategies varied significantly from US$ 73 to US$ 8256. There were also four main strategies for HCV patients, each of these could be applied in two periods of time. The total cost of these treatment strategies showed a high disc repancy from US$ 242 to US$ 8256.Conclusion: The results confirmed that the total direct medical cost for an HBV patient in Iran exceeded US$ 5.5 Milliard in 2011. The results implied that the market price of direct medical cost of HBV and HCV patients in Iran is much higher than the estimated state costs. These costs would likely be saved or reduced by effective disease management and early prevention.

Cites

References

  • No record.

    • Cite

    APA: Copy

    KALANTARI, HAMID, DAVARI, MAJID, AKBARI, MOJTABA, HEJAZI, SEYED MEHDI, KALANTARI, MARYAM, ZAKERIN, SHAHRAM, & SHAHSHAHAN, ZAHRA. (2012). THE ESTIMATION OF DIRECT MEDICAL COSTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS B AND C IN IRAN. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 3(3), 191-196. SID. https://sid.ir/paper/316029/en

    Vancouver: Copy

    KALANTARI HAMID, DAVARI MAJID, AKBARI MOJTABA, HEJAZI SEYED MEHDI, KALANTARI MARYAM, ZAKERIN SHAHRAM, SHAHSHAHAN ZAHRA. THE ESTIMATION OF DIRECT MEDICAL COSTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS B AND C IN IRAN. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE[Internet]. 2012;3(3):191-196. Available from: https://sid.ir/paper/316029/en

    IEEE: Copy

    HAMID KALANTARI, MAJID DAVARI, MOJTABA AKBARI, SEYED MEHDI HEJAZI, MARYAM KALANTARI, SHAHRAM ZAKERIN, and ZAHRA SHAHSHAHAN, “THE ESTIMATION OF DIRECT MEDICAL COSTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS B AND C IN IRAN,” INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, vol. 3, no. 3, pp. 191–196, 2012, [Online]. Available: https://sid.ir/paper/316029/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button